Submission of Newspaper Advertisement of Audited Financials Results for the Quarter and Year ended March 31, 2025 of the Company.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemo Pharma Laboratories Limited has submitted to BSE copies of newspaper advertisements of its audited financial results for Q4 and full year ended March 31, 2025, as published in Business Standard and Mumbai Lakshdeep on May 30, 2025. For Q4 FY25, the company reported a net loss of Rs 3.40 lakh (vs a loss of Rs 1.75 lakh in Q4 FY24), with negative total income from operations of Rs 1.64 lakh. For full year FY25, however, the company posted a net profit of Rs 34.22 lakh, down sharply from Rs 1.20 crore in FY24, on total operating income of Rs 61.98 lakh (vs Rs 1.84 crore last year). Basic EPS for FY25 came in at Rs 2.28 versus Rs 8.00 in FY24, while Q4 FY25 EPS was a negative Rs 2.26. Equity share capital stood unchanged at Rs 1.5 crore with reserves of Rs 11.64 crore, and the company has no subsidiaries or associates.
The company remained profitable for the full year but saw a steep YoY drop in both revenue and profits, with a quarterly loss highlighting weakening momentum. The detailed results are available on the BSE and company website for shareholders to review.